OSTX

OS Therapies (OSTX)

About OS Therapies (OSTX)

OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Grasonville, MD.

Details

Daily high

$1.71

Daily low

$1.61

Price at open

$1.68

52 Week High

$7.00

52 Week Low

$1.12

Market cap

58.8M

Dividend yield

0.00%

Volume

4,194

Avg. volume

390,643

P/E ratio

-2.05

OS Therapies News